The molar hydrodynamic volume changes of factor VIIa due to GlycoPEGylation

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 3, 2011, Pages 597-602

  Plesner, Bitten ^a,b   Westh, Peter ^a   Hvidt, Søren ^a   Nielsen, Anders D ^b  

^a ROSKILDE UNIVERSITY   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Capillary viscometry; GlycoPEGylation; Intrinsic viscosity; Molar hydrodynamic volume; RFVIIa

Indexed keywords

BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD VISCOSITY; CONTROLLED STUDY; HYDRODYNAMICS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; VISCOMETRY;

ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR VIIA; HUMANS; HYDRODYNAMICS; MOLECULAR WEIGHT; RECOMBINANT PROTEINS; SOLUTIONS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VISCOSITY;

EID: 79953171840     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.02.028     Document Type: Article

References (23)

1. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade - initiation, maintenance, and regulation. Biochemistry 1991, 30:10363-10370.
2. Wildgoose P., Foster D., Schiodt J., Wiberg F.C., Birktoft J.J., Petersen L.C. Identification of a calcium-binding site in the protease domain of human blood-coagulation factor-VII - evidence for its role in factor-VII tissue factor interaction. Biochemistry 1993, 32:114-119.
3. Manco-Johnson M.J., Abshire T.C., Shapiro A.D., Riske B., Hacker M.R., Kilcoyne R., Ingram J.D., Manco-Johnson M.L., Funk S., Jacobson L., Valentino L.A., Hoots W.K., Buchanan G.R., DiMichele D., Recht M., Brown D., Leissinger C., Bleak S., Cohen A., Mathew P., Matsunaga A., Medeiros D., Nugent D., Thomas G.A., Thompson A.A., McRedmond K., Soucie J.M., Austin H., Evatt B.L. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N. Engl. J. Med. 2007, 357:535-544.
4. Konkle B.A., Ebbesen L.S., Erhardtsen E., Bianco R.P., Lissitchkov T., Rusen L., Serban M.A. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J. Thromb. Haemost. 2007, 5:1904-1913.
5. Sen P., Ghosh S., Ezban M., Pendurthi U.R., Rao L.V.M. Effect of glycoPEGylation on factor VIIa binding and internalization. Haemophilia 2010, 16:339-348.
6. Pasut G., Guiotto A., Veronese F. Protein, peptide and non-peptide drug PEGylation for therapeutic application. Expert Opin. Ther. Patents 2004, 14:859-894.
7. Veronese F.M., Mero A., Pasut G. Protein PEGylation, basic science and biological applications. PEGylated Protein Drugs: Basic Science and Clinical Applications 2009, 11-31. Birkhauser Verlag Press, Basel. F.M. Veronese (Ed.).
8. Stennicke H.R., Ostergaard H., Bayer R.J., Kalo M.S., Kinealy K., Holm P.K., Sorensen B.B., Zopf D., Bjorn S.E. Generation and biochemical characterization of glycoPEGylated factor VIIa derivatives. Thromb. Haemost. 2008, 100:920-928.
9. Zalipsky S., Harris J.M. Chemistry and biological applications of PEG. Poly(ethylene glycol) Chemistry and Biological Application 1997, 1-13. American Chemical Society, Washington, DC. J.M. Harris, S. Zalipsky (Eds.).
10. Morar A.S., Schrimsher J.R.L., Chavez M.D. PEGylation of proteins: a structural approach. Biopharm. Int. 2006, 19:34-49.
11. Zalipsky S. Chemistry of polyethylene-glycol conjugates with biologically-active molecules. Adv. Drug Deliv. Rev. 1995, 16:157-182.
12. Harris J.M., Martin N.E., Modi M. Pegylation - a novel process for modifying pharmacokinetics. Clin. Pharmacokinet. 2001, 40:539-551.
13. Kurfurst M.M. Detection and molecular-weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl-sulfate polyacrylamide-gel electrophoresis. Anal. Biochem. 1992, 200:244-248.
14. Cannon M.R., Manning R.E., Bell J.D. Viscosity measurement - the kinetic energy correction and a new viscometer. Anal. Chem. 1960, 32:355-358.
15. Kunitani M., Dollinger G., Johnson D., Kresin L. Online characterization of polyethylene glycol-modified proteins. J. Chromatogr. 1991, 588:125-137.
16. Odom O.W., Kudlicki W., Kramer G., Hardesty B. An effect of polyethylene glycol 8000 on protein mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and a method for eliminating this effect. Anal. Biochem. 1997, 245:249-252.
17. Tong Y., Zhong K., Tian H., Gao X.D., Xu X.Y., Yin X.J., Yao W.B. Characterization of a monoPEG20000-Endostar. Int. J. Biol. Macromol. 2010, 46:331-336.
18. Banner D.W., Darcy A., Chene C., Winkler F.K., Guha A., Konigsberg W.H., Nemerson Y., Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996, 380:41-46.
19. Huggins M.L. The viscosity of dilute solutions of long-chain molecules. IV. Dependence on concentration. J. Am. Chem. Soc. 1942, 64:2716-2718.
20. Kraemer E.O. Molecular weights of celluloses and cellulose derivates. Ind. Eng. Chem. 1938, 30:1200-1203.
21. Manjula B.N., Tsai S., Upadhya R., Perumalsamy K., Smith P.K., Malavalli A., Vandegriff K., Winslow R.M., Intaglietta M., Prabhakaran M., Friedman J.M., Acharya A.S. Correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug. Chem. 2003, 14:464-472.
22. Maxfield J., Shepherd I.W. Conformation of poly(ethylene oxide) in solid-state, melt and solution measured by Raman-scattering. Polymer 1975, 16:505-509.
23. Dhalluin C., Ross A., Leuthold L.A., Foser S., Gsell B., Muller F., Senn H. Structural and biophysical characterization of the 40kDa PEG-interferon-alpha(2a) and its individual positional isomers. Bioconjug. Chem. 2005, 16:504-517.